INFLAMMATIX
Live / Applied — Fourth extension granted (statement of use) (as of 24 Mar 2026)
What this means for you
Not registered yet, but its 27 Apr 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97384871
- Mark type
- Stylized text
- Filed
- 27 Apr 2022
- Published for opposition
- 30 Jan 2024
- Attorney of record
- Stephanie Bald
Goods and services
- Class 005 — Pharmaceuticals: Medical diagnostic assays for use in gene expression tests, gene expression profiling assays, analyzing genetic information, analyzing and detecting protein biomarkers, analysis of biomarker levels and/or for use in analyzing relative expressions of host response
- Class 010 — Medical apparatus: Medical and diagnostic apparatus for use in gene expression tests, gene expression profiling assays, analyzing genetic information, analyzing and detecting protein biomarkers, analyzing clinical data, and/or analyzing demographic information; medical and diagnostic apparatus for analysis of biomarker levels and/or relative expression of host response genes; medical and diagnostic apparatus for analyzing gene expression using bioinformatics and machine learning algorithms; medical and diagnostic apparatus for gene expression tests, gene expression profiling assays, analyzing genetic information, analyzing protein biomarkers, analyzing clinical data and/or demographic information to aid treatment decisions
- Class 044 — Medical, beauty and agricultural services: Medical diagnostic services in the field of diagnostic testing services; medical diagnostic services for gene expression testing, gene expression profiling, analyzing genetic information, analyzing and detecting protein biomarkers, analyzing biomarker levels and/or analyzing relative expressions of host response
Owner
- Inflammatix, Inc., Sunnyvale, CA, US
- Inflammatix, Inc., Sunnyvale, CA, US
Prosecution history
- 25 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Mar 2026 — TEAS STATEMENT OF USE RECEIVED
- 24 Mar 2026 — SOU EXTENSION 4 GRANTED
- 24 Mar 2026 — SOU EXTENSION 4 FILED
- 24 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 26 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Sept 2025 — SOU EXTENSION 3 GRANTED
- 25 Sept 2025 — SOU EXTENSION 3 FILED
- 25 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 12 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Mar 2025 — SOU EXTENSION 2 GRANTED
- 12 Mar 2025 — SOU EXTENSION 2 FILED
- 12 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 23 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Sept 2024 — SOU EXTENSION 1 GRANTED